Clinical trials
Recruiting Phase 1/2 Hematologic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 26 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| BeOne Medicines | 1 |
| Beijing Biotech | 1 |
| CellCentric Ltd. | 1 |
| Chinese PLA General Hospital | 1 |
| Curis, Inc. | 1 |
| Daiichi Sankyo | 1 |
| Fred Hutchinson Cancer Center | 1 |
| Grit Biotechnology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 26 |
| Leukemia, Myeloid, Acute | 9 |
| Lymphoma, Non-Hodgkin | 5 |
| Multiple Myeloma | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Recurrence | 3 |
| Bronchiolitis Obliterans Syndrome | 2 |
| Leukemia, Biphenotypic, Acute | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Lymphoma | 2 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.